PharmacyCodes



Tetradecyl sodium sulfate en es it fr

Tetradecyl sodium sulfate Brand names, Tetradecyl sodium sulfate Analogs

Tetradecyl sodium sulfate Brand Names Mixture

  • No information avaliable

Tetradecyl sodium sulfate Chemical_Formula

C14H30O4S

Tetradecyl sodium sulfate RX_link

http://www.rxlist.com/cgi/generic2/sotradecol.htm

Tetradecyl sodium sulfate fda sheet

Tetradecyl sodium sulfate msds (material safety sheet)

Tetradecyl_sodium_sulfate MSDS

Tetradecyl sodium sulfate Synthesis Reference

No information avaliable

Tetradecyl sodium sulfate Molecular Weight

294.452 g/mol

Tetradecyl sodium sulfate Melting Point

No information avaliable

Tetradecyl sodium sulfate H2O Solubility

No information avaliable

Tetradecyl sodium sulfate State

Solid

Tetradecyl sodium sulfate LogP

No information avaliable

Tetradecyl sodium sulfate Dosage Forms

Solution for intramuscular injection

Tetradecyl sodium sulfate Indication

For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.

Tetradecyl sodium sulfate Pharmacology

Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.

Tetradecyl sodium sulfate Absorption

No information avaliable

Tetradecyl sodium sulfate side effects and Toxicity

LD50=1250 mg/kg (Orally in rat); LD50=3 ml/kg (Skin in rat)

Tetradecyl sodium sulfate Patient Information

No information avaliable

Tetradecyl sodium sulfate Organisms Affected

Humans and other mammals